{"ok":true,"api":{"name":"SAIMSARA Evidence Object Discovery API","version":"v1"},"mode":"doc_key","editorial_verification":{"status":"human_reviewed","trust_label":"machine_generated_human_reviewed","method":"World ID proof-of-human editorial account","scope":["clinical_integrity","reference_quality","scientific_coherence"],"verification_note":"This Evidence Object is machine-generated and human-reviewed. World ID is used to verify that editorial oversight was submitted by a unique human account.","does_not_mean":"World ID verifies proof-of-human editorial oversight; it does not independently certify the scientific truth of every claim."},"object":{"object_type":"saimsara_evidence_object_metadata","doc_key":"infections::EBOLA_PM","issue_slug":"infections","doc_id":"EBOLA_PM","title":"Ebola Virus Disease, Vaccines, Therapeutics, Transmission, and Long-Term Sequelae","doi":"10.62487/saimsara976931fc","doi_url":"https://doi.org/10.62487/saimsara976931fc","version":"2026-06-06","source_name":"PubMed","article_url":"https://saimsara.com/sessions/ebola-virus-disease-20260529-105528-976931fc/","image_url":"https://youtu.be/hJwYR_1d0KI","topic_tags":"Ebola virus disease,Ebola virus,EBOV transmission,Ebola outbreaks,case fatality,EVD survivors,long-term sequelae,rVSV-ZEBOV vaccine,Ebola treatment units,viral persistence","keywords":["Ebola virus disease","Ebola virus","EBOV transmission","Ebola outbreaks","case fatality","EVD survivors","long-term sequelae","rVSV-ZEBOV vaccine","Ebola treatment units","viral persistence"],"metrics":{"included_all":4089,"included_original":2251,"reference_index":810,"total_participants":4785212},"discover_url":"https://saimsara.com/api/v1/discover.php?doc_key=infections%3A%3AEBOLA_PM","paid_evidence_url":"https://saimsara.com/api/v1/evidence.php?doc_key=infections%3A%3AEBOLA_PM","price":{"amount":"5.00","currency":"USD","units":5,"unit_amount":"1.00"},"payment_methods":["api_key","stripe_checkout","object_grant","x402"],"text_length":121970,"preview":"Results Key finding aligned to the query: Across the included studies, the most consistent paper-level finding is that EVD is a high-mortality, system-sensitive disease in which acute outcome is repeatedly shaped by viral burden, age, organ injury, and timeliness of effective care, while transmission control depends on rapid diagnosis, isolation, contact tracing, safe burial, vaccination, and community trust. Multiple clinical cohorts identified high viral load or low cycle threshold as a central prognostic marker, with survival markedly higher among patients with lower viral loads or higher cycle threshold values. Population and treatment studies also showed that prevention and care innovat…","trust_label":"machine_generated_human_reviewed","editorial_verification":{"status":"human_reviewed","trust_label":"machine_generated_human_reviewed","method":"World ID proof-of-human editorial account","scope":["clinical_integrity","reference_quality","scientific_coherence"],"verification_note":"This Evidence Object is machine-generated and human-reviewed. World ID is used to verify that editorial oversight was submitted by a unique human account.","does_not_mean":"World ID verifies proof-of-human editorial oversight; it does not independently certify the scientific truth of every claim."},"checkout":{"method":"POST","url":"https://saimsara.com/create_checkout_session.php","content_type":"application/x-www-form-urlencoded","params":{"plan":"evidence_object","doc_key":"infections::EBOLA_PM"},"optional_params":{"customer_email":"user@example.com"},"price":{"amount":"5.00","currency":"USD","units":5,"unit_amount":"1.00"},"curl_example":"curl -X POST https://saimsara.com/create_checkout_session.php -d \"plan=evidence_object\" -d \"doc_key=infections::EBOLA_PM\" -d \"customer_email=user@example.com\""},"access_after_payment":{"header":"X-SAIMSARA-Payment-Proof","endpoint":"https://saimsara.com/api/v1/evidence.php?doc_key=infections%3A%3AEBOLA_PM","curl_example":"curl -H \"X-SAIMSARA-Payment-Proof: YOUR_PAYMENT_PROOF_TOKEN\" \"https://saimsara.com/api/v1/evidence.php?doc_key=infections%3A%3AEBOLA_PM\""}}}